The Japan Times CENTER (0.0) Reliability: 7.5/10

Breast cancer patients lived longer on drug Datroway, says maker

✍️ Ashleigh Furlong 📅 October 07, 2025 12:00 AM 🕐 Scraped: October 07, 2025

Summary: The drug is said to have significantly improved survival and delayed disease progression in patients with a particularly hard to treat form of the disease.

AstraZeneca and Daiichi Sankyo’s drug Datroway has helped breast cancer patients with a particularly hard to treat form of the disease live longer.

Datroway significantly improved survival and also delayed the progression of the d

📰

Continue Reading on The Japan Times

This preview shows approximately 15% of the article. Read the full story on the publisher's website to support quality journalism.

Read Full Article →

How do you feel about this article?

Read Original Article →

📝 Article Information

Author

Ashleigh Furlong

Original Publisher

🌍 The Japan Times

CENTER Bias (0.0)

Published Date

October 07, 2025 at 12:00 AM

ℹ️

Disclaimer

ArkforgeAI.com - Newsource is a news aggregation platform. We do not create, write, or produce original news content. All articles are sourced from their respective publishers and remain the property of their original creators. We analyze and aggregate news from multiple sources to provide diverse perspectives across the political spectrum.

The content displayed here is for informational purposes only. For the complete and original article, please visit the source's website using the "Read Original Article" link above.

Desktop Only